Respiratory Diseases Unit, Department of Internal Medicine, Azienda Ospedaliero-Universitaria, Ospedali Riuniti, Ancona, Italy,
Respiratory Diseases Unit, Department of Internal Medicine, Azienda Ospedaliero-Universitaria, Ospedali Riuniti, Ancona, Italy.
Respiration. 2021;100(1):77-87. doi: 10.1159/000511626. Epub 2020 Dec 29.
Diagnostic yield (DY) and safety of computed tomography (CT)- and thoracic ultrasound (TUS)-guided biopsies in the diagnosis of pleural lesions have been investigated in a number of studies, but no synthesis of data from the literature has ever been performed.
We aimed to provide the first systematic review and meta-analysis on the DY and safety of CT- versus TUS-guided biopsy in the diagnosis of pleural lesions.
We searched MEDLINE and EMBASE for all studies reporting outcomes of interest published up to April 2018. Two authors reviewed all titles/abstracts and retrieved selected full text to identify studies according to predefined selection criteria. Summary estimates were derived using the random-effects model. Cumulative meta-analysis assessed the influence of increasing adoption of the procedures over time.
Thirty original studies were included in the present review; the number of studies on TUS-guided biopsy was almost three-fold higher than those on CT-guided biopsy. The pooled DYs of the 2 procedures were overall excellent and differed <10%, being 84% for TUS-guided biopsy and 93% for CT-guided biopsy. Safety profiles were reassuring for both the techniques, being 7 and 3% for CT- and TUS-guided biopsy, respectively. DY of ultrasound technique significantly improved over time, while no time effect was observed for CT-guided biopsy.
Data show that CT- and TUS-guided biopsies in the diagnosis of pleural lesions are both excellent procedures, without meaningful differences in DYs and safety. Considering that TUS is non-ionizing and easily performed at the bedside, it should be the preferred approach in presence of adequate skills.
在许多研究中已经研究了计算机断层扫描(CT)和胸腔超声(TUS)引导下活检在诊断胸膜病变中的诊断收益(DY)和安全性,但从未对文献中的数据进行综合分析。
我们旨在对 CT 与 TUS 引导下活检在胸膜病变诊断中的 DY 和安全性进行首次系统评价和荟萃分析。
我们在 MEDLINE 和 EMBASE 中搜索了截至 2018 年 4 月发表的所有报告感兴趣结局的研究。两名作者根据预先设定的选择标准,对所有标题/摘要进行了回顾,并检索了选定的全文,以确定研究。使用随机效应模型得出汇总估计值。累积荟萃分析评估了随着时间的推移,程序采用率的增加对结果的影响。
本综述共纳入 30 项原始研究;TUS 引导下活检的研究数量几乎是 CT 引导下活检的三倍。两种方法的 DY 总体上均非常出色,差异<10%,TUS 引导下活检为 84%,CT 引导下活检为 93%。两种技术的安全性均令人放心,CT 引导下活检的安全性为 7%,TUS 引导下活检的安全性为 3%。随着时间的推移,超声技术的 DY 显著提高,而 CT 引导下活检未观察到时间效应。
数据表明,CT 和 TUS 引导下活检在胸膜病变的诊断中均是出色的方法,在 DY 和安全性方面无显著差异。鉴于 TUS 是非电离的,并且可以在床边轻松进行,在具备足够技能的情况下,它应该是首选方法。